[1] 王增武,代表《中国心血管健康与疾病报告》编写组.中国高血压流行和防治现状[J].中国心血管病研究, 2022,20(8):673-678.DOI: 10.3969/j.issn.1672-5301.2022.08.001. [2] DASINGER J H, DAVIS G K, NEWSOME A D, et al. Developmental programming of hypertension: physiological mechanisms[J]. Hypertension, 2016, 68(4): 826-831. DOI: 10.1161/HYPERTENSIONAHA.116.06603. [3] KRISHNAN S M, LING Y H, HUUSKES B M, et al. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension[J]. Cardiovasc Res, 2019, 115(4): 776-787. DOI: 10.1093/cvr/cvy252. [4] HEADRICK J P, ASHTON K J, ROSE'MEYER R B, et al. Cardiovascular adenosine receptors: expression, actions and interactions[J]. Pharmacol Ther, 2013, 140(1): 92-111. DOI: 10.1016/j.pharmthera.2013.06.002. [5] BURNSTOCK G. Purinergic signalling and endothelium[J]. Curr Vasc Pharmacol, 2016, 14(2): 130-145. DOI: 10.2174/1570161114666151202204948. [6] LI L Z, YUE L H, ZHANG Z M, et al. Comparison of mRNA expression of P2X receptor subtypes in different arterial tissues of rats[J]. Biochem Genet, 2020, 58(5): 677-690. DOI: 10.1007/s10528-020-09968-9. [7] ZHOU Z C, SOROP O, DE BEER V J, et al. Altered purinergic signaling in uridine adenosine tetraphosphate-induced coronary relaxation in swine with metabolic derangement[J]. Purinergic Signal, 2017, 13(3): 319-329. DOI: 10.1007/s11302-017-9563-6. [8] ZHOU Z C, MATSUMOTO T, JANKOWSKI V, et al. Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: an update[J]. Pharmacol Res, 2019, 141: 32-45. DOI: 10.1016/j.phrs.2018.12.009. [9] BROWN I A M, DIEDERICH L, GOOD M E, et al. Vascular smooth muscle remodeling in conductive and resistance arteries in hypertension[J]. Arterioscler Thromb Vasc Biol, 2018, 38(9): 1969-1985. DOI: 10.1161/ATVBAHA.118.311229. [10] HANSEN P B, HRISTOVSKA A, WOLFF H, et al. Uridine adenosine tetraphosphate affects contractility of mouse aorta and decreases blood pressure in conscious rats and mice[J]. Acta Physiol(Oxf), 2010, 200(2): 171-179. DOI: 10.1111/j.1748-1716.2010.02135.x. [11] LINDER A E, TUMBRI M, LINDER F F, et al. Uridine adenosine tetraphosphate induces contraction and relaxation in rat aorta[J]. Vascul Pharmacol, 2008, 48(4/5/6): 202-207. DOI: 10.1016/j.vph.2008.03.003. [12] ZHOU Z C, YADAV V R, SUN C Y, et al. Impaired aortic contractility to uridine adenosine tetraphosphate in angiotensin II-induced hypertensive mice: receptor desensitization?[J]. Am J Hypertens, 2017, 30(3): 304-312. DOI: 10.1093/ajh/hpw163. [13] GUI Y, WALSH M P, JANKOWSKI V, et al. Up4A stimulates endothelium-independent contraction of isolated rat pulmonary artery[J]. Am J Physiol Lung Cell Mol Physiol, 2008, 294(4): L733-L738. DOI: 10.1152/ajplung.00403.2007. |